News News

Sirnaomics News Placeholder 04
June 6, 2018 Sirnaomics Closed Series C1 Financing of US$25 Million and Expands Clinical Programs

This round of financing was led by Yuexiu New Industrial Investment, followed by Sangel Biomedical Venture Capital, HuaKong Equity Investment and Qianhai Shenghui Investment.

Sirnaomics China
May 3, 2018 Dr. Steven Long Joins Sirnaomics Senior Management Team as Head of China Clinical Studies

Dr. Long will be responsible for clinical studies performed in China. His extensive experience and knowledge in preclinical and clinical regulations will strengthen Sirnaomics clinical programs for novel siRNA therapeutic development in China.

December 6, 2017 Sirnaomics’ STP705 Granted Orphan Designation for Treatment of Cholangiocarcinoma

Sirnaomics announced today that the Office of Orphan Product Development division of the FDA has granted Orphan-drug designation to its leading therapeutic candidate, STP705, for the treatment of Cholangiocarcinoma (CCA).

Sirnaomics News Placeholder 02
October 6, 2017 Sirnaomics Publishes Results Showing Effective Dual Targeting

The manuscript is titled “Simultaneous silencing of TGF-β1 and COX-2 reduces human skin hypertrophic scar through activation of fibroblast apoptosis” (Oncotarget, September, 2017).

Sirnaomics News Placeholder 01
August 1, 2017 Sirnaomics Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for PSC

Sirnaomics announced today that the Office of Orphan Product Development division of the USA FDA has granted Orphan Drug Designation to its leading therapeutic candidate, STP705, for the treatment of Primary Sclerosing Cholangitis (PSC).

Sirnaomics News Placeholder 05
June 15, 2017 Sirnaomics Advances Leading siRNA Therapeutic Candidate, STP705, for Treatment of Liver Fibrosis

Sirnaomics announced today that it has received reports from efficacy studies with CCL4-Induced mouse liver fibrosis model for its lead siRNA therapeutic candidate, STP705 (Cotsiranib®), from two contract research companies.

1 7 8 9 10 11 12